Frequently Asked Questions
The market is segmented based on , By Product Type (Tablet, Capsule, Microchip Delivery Device), Indication (Mental Disorders, Cancer, Infectious Diseases, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Mail Order Pharmacies), Diseases (Cardiovascular Diseases, Infectious Diseases, Diabetes, Cancer, Others), End-User (Hospitals, Clinics, Home Care Settings, Others) – Industry Trends and Forecast to 2031.
.
The Global Digital Pills Market size was valued at USD 4.27 USD Billion in 2023.
The Global Digital Pills Market is projected to grow at a CAGR of 8.35% during the forecast period of 2024 to 2031.
The major players operating in the market include 2morrow , Otsuka Holdings Co, Pure Tech, Teladoc Health , AliveCor , Abbott, Olympus Corporation, Medtronic, Smith+Nephew, Novartis AG, Omada Health , Mocacare, GENTAG , Zio by iRhythm Technologies , Perficient , BDD Ltd, CapsoVision , Ginger, Welldoc .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
